$67.15 +$1.29 (+1.96%)
休市 · Nov 8, 5:50 am ET · 最新盘后价 $67.15 0.00%
开盘$66.07
昨收$65.86
当日区间$64.52 – $67.54
成交量2.48M
市值$13.36B
市盈率（TTM）36.1
股息率–
BTSG 相关新闻
匹配 BrightSpring Health Services 或代码 BTSG 的头条新闻，按最新排序。
- UBS Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Maintains Target Price $85
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (OtherSNYNF), Amgen (AMGN) and BrightSpring Health Services, Inc. (BTSG)
- Jefferies Sticks to Its Buy Rating for BrightSpring Health Services, Inc. (BTSG)
- A Quick Look at Today's Ratings for BrightSpring Health Services(BTSG.US), With a Forecast Between $70 to $90
- KeyBanc Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Maintains Target Price $80
- Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE), BrightSpring Health Services, Inc. (BTSG) and AgomAb Therapeutics NV ADR (AGMB)
- BTIG Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Maintains Target Price $90
- Wells Fargo Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Maintains Target Price $78
- Analysts' Opinions Are Mixed on These Healthcare Stocks: BrightSpring Health Services, Inc. (BTSG), AbbVie (ABBV) and Novo Nordisk (NVO)
- Analysts Conflicted on These Healthcare Names: BrightSpring Health Services, Inc. (BTSG), Inventiva (IVA) and Moderna (MRNA)
- BMO Capital Keeps Their Buy Rating on BrightSpring Health Services, Inc. (BTSG)
- Analysts Offer Insights on Healthcare Companies: Citius Pharmaceuticals (CTXR) and BrightSpring Health Services, Inc. (BTSG)
- TD Cowen Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Maintains Target Price $81
- Mizuho Securities Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Maintains Target Price $86
- William Blair Maintains BrightSpring Health Services(BTSG.US) With Buy Rating
暂无评论——快来第一个聊聊 BTSG。
登录后参与讨论。